ダウンロード数: 521

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
s11010-011-0838-x.pdf342.55 kBAdobe PDF見る/開く
タイトル: NADPH regulates human NAD kinase, a NADP⁺-biosynthetic enzyme.
著者: Ohashi, Kazuto
Kawai, Shigeyuki  KAKEN_id
Koshimizu, Mari
Murata, Kousaku
著者名の別形: 河井, 重幸
村田, 幸作
キーワード: NAD kinase
Human
Drug design
NADP+
NADPH
NADH
発行日: Sep-2011
出版者: Springer Science+Business Media, LLC.
誌名: Molecular and cellular biochemistry
巻: 355
号: 1-2
開始ページ: 57
終了ページ: 64
抄録: NAD kinase (NADK, EC 2.7.1.23) is the sole NADP(+)-biosynthetic enzyme that catalyzes phosphorylation of NAD(+) to yield NADP(+) using ATP as a phosphoryl donor, and thus, plays a vital role in the cell and represents a potentially powerful antimicrobial drug target. Although methods for expression and purification of human NADK have been previously established (Lerner et al. Biochem Biophys Res Commun 288:69-74, 2001), the purification procedure could be significantly improved. In this study, we improved the method for expression and purification of human NADK in Escherichia coli and obtained a purified homogeneous enzyme only through heat treatment and single column chromatography. Using the purified human NADK, we revealed a sigmoidal kinetic behavior toward ATP and the inhibitory effects of NADPH and NADH, but not of NADP(+), on the catalytic activity of the enzyme. These inhibitory effects provide insight into the regulation of intracellular NADPH synthesis. Furthermore, these attributes may provide a clue to design a novel drug against Mycobacterium tuberculosis in which this bacterial NADK is potently inhibited by NADP(+).
著作権等: The final publication is available at www.springerlink.com
This is not the published version. Please cite only the published version.
この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。
URI: http://hdl.handle.net/2433/147259
DOI(出版社版): 10.1007/s11010-011-0838-x
PubMed ID: 21526340
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。